Abstract
There are geographic and ethnic differences in the incidence of gastric cancer around the world as well as with its trends for each population over time. The incidence patterns observed among immigrants change according to where they live. All of these factors indicate the close association of gastric cancer with diet. This review presents epidemiological evidence on the association between dietary factors and gastric cancer. Infection with Helicobacter pylori is a strong risk factor of gastric cancer however smoking, alcohol, diet, genetics and epigenetic factors may also play a role in the occurrence of this disease. The risk may be increased with a high intake of various traditional salt-preserved foods and decreased with a high intake of fruit and vegetables. Among them, vitamin C is a probable candidate supported by a relatively large group of epidemiological evidence. Consumption of green tea is possibly associated with a decreased risk of gastric cancer. In contrast, processed meat and N-nitroso compounds may be positively associated with the risk of gastric cancer. In conclusion, dietary modification by reducing salt and salted food intake, as well as by increasing intake of fruit and vitamin C, represents a practical strategy to prevent gastric cancer.
References
Hamilton JP, Meltzer SJ. (2006) Clin Gastroenterol Hepatol. 4:416-425.
Parkin DM, Bray F, Ferlay J, Pisani P.(2005) CA Cancer J Clin. 55: 74–108.
Tsugane S , Sasazuki S.(2007) Gastric Cancer. 10:75- 83.
Ghosh S, Guria S, Das M. (2015) Proc Zool Soc. DOI 10.1007/s12595-014-0134-3
Weisburger JH, Chung FL.(2002) Food Chem Toxicol .40:1145-1154.
Qurieshi MA, Masoodi MA, Kadla SA, Ahmad SZ, Gangadharan P.(2011) Asian Pac J Cancer Prev. 12(1): 303-307.
Pavithran K, Doval DC, Pandey KK.(2002) Gastric Cancer.5(4):240-243.
Malhotra SL. (1967) Gut. 8(4): 361-372.
Mathew A, Gangadharan P, Varghese C, Nair MK.(2000) Eur J Cancer Prev. 9(2):989-997.
Phukan RK, Narain K, Zomawia E, Hazarika NC, Mahanta J. (2006) J Gastroenterol.41(5): 418-424.
Oiso T. (1975) Cancer Res.35: 3254-3258.
Chen VW, Abu-Elyazeed RR, Zavala DE, Ktsanes VK, Haenszel W, Cuello C, Montes G, Correa P. (1990) Nutr Cancer.13: 59-65.
Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, Tanizaki Y, Doi Y, Tanaka K, Oishi Y.(2006) Int J Cancer.119: 196-201.
You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, Li JY, Jin ML, Hu YR, Yang CS.(2000) J Natl Cancer Inst.92: 1607-1612.
Ahmed N, Sechi LA. (2005) Ann Clin Microbiol Antimicrob. 4(1): doi:10.1186/1476-0711-4-1.
Kanneganti TD, Dixit VD.(2012) Nat Immunol.13: 707– 712.
Moon HS, Liu X, Nagel JM, Chamberland JP, Diakopoulos KN, Brinkoetter MT, Hatziapostolou M, Wu Y, Robson SC, Iliopoulos D, Mantzoros CS. (2013) Gut. 62: 561–570.
Kim YI. (2004) Cancer Epidemiol Biomarkers Prev. 13: 511–519.
Shitara K, Muro K, Ito S, Sawaki A, Tajika M, Kawai H, Yokota T, Takahari D, Shibata T, Ura T, Ito H, Hosono S, Kawase T, Watanabe M, Tajima K, Yatabe Y, Tanaka H, Matsuo K. (2010) Cancer Epidemiol Biomarkers Prev. 19: 1311–1319.
Wang ZY, Cheng SJ, Zhou ZC, Athar M, Khan WA, Bickers DR. (1989) Mutat Res.,223: 273–285.
Yang CS, Maliakal P, Meng X.(2002) Annu Rev Pharmacol Toxicol.42: 25–54.
Drake IM, Davies MJ, Mapstone NP, Dixon MF, Schorah CJ, White KL, et al. (1996) Carcinogenesis. 17: 559– 562.
Cover TL, Peek RM Jr. (2013) Gut Microbes. 4(6): 482–493.
Nomura A, Chyou PH, Stemmermann GN. (1992) Cancer Epidemiol Biomarkers Prev.1: 547-550.
Yip R, Limburg PJ, Ahlquist DA, Carpenter HA, O’Neill A, Kruse D, Stitham S, Gold BD, Gunter EW, Looker AC.(1997) JAMA. 277: 1135-1139.
Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC.(2013) J Clin Invest.123:479-492.
López-Carrillo L, Hernández Avila M, Dubrow R. (1994) Am J Epidemiol.139(3): 263-271.
Bode AM, Dong Z.(2011) Cancer Res. 71(8): 2809- 2814.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array